Generic drug developer Syngen Biotech Co (生展生技) said yesterday that it aims to increase its market share of antibiotic mupirocin from 10 percent to between 20 percent and 30 percent in the near future.
The global market for mupirocin is worth about US$228 million a year, the firm said.
“We purchased the technology and patents of mupirocin, and our manufacturing process has evolved significantly after making the drug for four to five years,” Syngen Biotech chairman Chen Wei-jen (陳威仁) said.
There are three companies making the drug around the world, while other firms are reluctant to enter the market because of its high entry barrier, Chen said.
Sales of mupirocin accounted for 13 percent of Syngen Biotech’s revenue of NT$387 million (US$12.6 billion) from January through September, the firm said, adding the drug has the highest gross margin of all its products.
The company is also developing mupirocin calcium, a similar antibiotic used in the nasal cavity and set to enter the market in 2016, Chen said.
Meanwhile, by cooperating with Sichuan Cangbao Cordyceps Sinesis Biotechnology (四川藏寶蟲草生技), the company successfully raised caterpillar fungus this year, Chen said, adding that the fungus is sold for 6,000 yuan (US$960) per 22.4g.
The company, set to start trading its shares on the Emerging Stock Market today, has capital of NT$171 million and it reported earnings per share of NT$1.22 in the first nine months of the year.
Last year, the company reported revenue of NT$275 million, earnings per share of NT$0.85.
CLIENTS’ RIGHTS: Banking Bureau Deputy Director-General Lin Chih-chi said the buyer and Citibank Taiwan would need to disclose changes to branch operations DBS Bank Taiwan (星展台灣), the local unit of Singapore-based DBS Group Holdings Ltd, has reportedly won a bid to acquire Citibank Taiwan Ltd’s (花旗台灣) consumer banking business, but the two companies declined to confirm the report yesterday. Citibank Taiwan’s consumer banking business is to be sold for about NT$60 billion (US$2.17 billion) to DBS Taiwan, the Chinese-language Economic Daily News reported on Sunday. DBS Taiwan and its parent company are expediting the negotiations with the seller’s US-based parent company, while other local bidders, including Fubon Financial Holding Co (富邦金控) and Cathay Financial Holding Co (國泰金控), have dropped their bids, the report said. Citibank
Intel Corp yesterday said it has placed its first order with ASML Holding NV to purchase the semiconductor industry’s first TWINSCAN EXE: 5200 system, as the US chip giant aims to compete with Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) in advancing to 2-nanometer process technology. The Dutch semiconductor equipment maker’s TWINSCAN EXE:5200 system is an extreme ultraviolet (EUV) high-volume production system with a high numerical aperture (NA) that can produce 220 wafers per hour, more than the 150 wafers that its previous generation TWINSCAN EXE:5000 system can handle. ASML aims to launch the new system in 2024. ASML president and chief
Siltronic AG cast doubt on a planned US$5.3 billion takeover by GlobalWafers Co (環球晶圓), saying the German Ministry of Economic Affairs and Climate Action’s feedback so far was opaque and offered no clear resolution on how to win approval for the deal. During recent discussions, the companies did not receive any information as to whether and under which conditions a clearance for the takeover might be issued, the German company said in a regulatory filing on Friday following a news report on remedies the companies have offered. In the ministry’s view “in this case, a mitigation agreement is apparently not suitable
BELLWETHER COMPANY: A failed fundraiser at Country Garden, thus far unaffected by issues at Evergrande, is feared to prompt widespread repricing of developer stocks A crisis engulfing China’s property sector is affecting its biggest developer, with Country Garden Holdings Co’s (碧桂園) shares and bonds hammered amid fears that a reportedly failed fundraising effort might be a harbinger of waning confidence. Country Garden is one of the few remaining large, better-quality private developers that had been largely unscathed by the liquidity crunch, even as peers, such as Shimao Group Holdings Ltd (世茂集團), saw dramatic reversals in their credit ratings. The firm is viewed as a bellwether for contagion risk, as unprecedented levels of stress in the offshore credit market threaten to drag good credits down alongside bad